Abad-Casintahan F, Chow SKW, Goh CL, Kubba R, Hayashi N, Noppakun N, et al. Frequency and characteristics of acne-related post-inflammatory hyperpigmentation. J Dermatol. 2016;43(7):826–8. https://doi.org/10.1111/1346-8138.13263.
Elbuluk N, Grimes P, Chien A, Hamzavi I, Alexis A, Taylor S, et al. The pathogenesis and management of acne-induced post-inflammatory hyperpigmentation. Am J Clin Dermatol. 2021;22(6):829–36. https://doi.org/10.1007/s40257-021-00633-4.
Abanmi A, Al-Enezi M, Al Hammadi A, Galadari I, Kibbi AG, Zimmo S. Survey of acne-related post-inflammatory hyperpigmentation in the Middle East. J Dermatolog Treat. 2019;30(6):578–81. https://doi.org/10.1080/09546634.2018.1542807.
Article CAS PubMed Google Scholar
Davis EC, Callender VD. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol. 2010;3(7):20–31.
PubMed PubMed Central Google Scholar
Tan MG, Kim WB, Jo CE, Nabieva K, Kirshen C, Ortiz AE. Topical treatment for postinflammatory hyperpigmentation: a systematic review. J Dermatolog Treat. 2022;33(5):2518–26. https://doi.org/10.1080/09546634.2021.1981814.
Article CAS PubMed Google Scholar
Alexis AF, Sergay AB, Taylor SC. Common dermatologic disorders in skin of color: a comparative practice survey. Cutis. 2007;80(5):387–94.
Layton A, Alexis A, Baldwin H, Beissert S, Bettoli V, Del Rosso J, et al. Identifying gaps and providing recommendations to address shortcomings in the investigation of acne sequelae by the Personalising Acne: Consensus of Experts Panel. JAAD Int. 2021;5:41–8. https://doi.org/10.1016/j.jdin.2021.06.006.
Article PubMed PubMed Central Google Scholar
Davis EC, Callender VD. A review of acne in ethnic skin: pathogenesis, clinical manifestations, and management strategies. J Clin Aesthet Dermatol. 2010;3(4):24–38.
PubMed PubMed Central Google Scholar
Alexis A, Del Rosso JQ, Forman S, Martorell A, Browning J, Laquer V, et al. Importance of treating acne sequelae in skin of color: 6-month phase IV study of trifarotene with an appropriate skincare routine including UV protection in acne-induced post-inflammatory hyperpigmentation. Int J Dermatol. 2024;63(6):806–15. https://doi.org/10.1111/ijd.17189.
Article CAS PubMed Google Scholar
Arsiwala S, Desai S. Fractional carbon dioxide laser: optimizing treatment outcomes for pigmented atrophic acne scars in skin of color. J Cutan Aesthet Surg. 2019;12(2):85–94. https://doi.org/10.4103/JCAS.JCAS_171_18.
Article PubMed PubMed Central Google Scholar
Silpa-Archa N, Kohli I, Chaowattanapanit S, Lim HW, Hamzavi I. Postinflammatory hyperpigmentation: a comprehensive overview: epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. J Am Acad Dermatol. 2017;77(4):591–605. https://doi.org/10.1016/j.jaad.2017.01.035.
Passeron T, Lim HW, Goh CL, Kang HY, Ly F, Morita A, et al. Photoprotection according to skin phototype and dermatoses: practical recommendations from an expert panel. J Eur Acad Dermatol Venereol. 2021;35(7):1460–9. https://doi.org/10.1111/jdv.17242.
Article CAS PubMed PubMed Central Google Scholar
Burns EM, Ahmed H, Isedeh PN, Kohli I, Van Der Pol W, Shaheen A, et al. Ultraviolet radiation, both UVA and UVB, influences the composition of the skin microbiome. Exp Dermatol. 2019;28(2):136–41. https://doi.org/10.1111/exd.13854.
Article CAS PubMed PubMed Central Google Scholar
Poli F. Acne on pigmented skin. Int J Dermatol. 2007;46(Suppl. 1):39–41. https://doi.org/10.1111/j.1365-4632.2007.03463.x.
Goh CL, Noppakun N, Micali G, Azizan NZ, Boonchai W, Chan Y, et al. Meeting the challenges of acne treatment in Asian patients: a review of the role of dermocosmetics as adjunctive therapy. J Cutan Aesthet Surg. 2016;9(2):85–92. https://doi.org/10.4103/0974-2077.184043.
Article PubMed PubMed Central Google Scholar
Features C. A review of the epidemiology, clinical features, and treatment options in skin of color. Year study population prevalence rank. 2010;3(7).
Al-Qarqaz F, Bodoor K, Baba A, Al-Yousef A, Muhaidat J, Alshiyab D. Post-acne hyperpigmentation: evaluation of risk factors and the use of artificial neural network as a predictive classifier. Dermatol Rep. 2021;13(3):8223. https://doi.org/10.4081/dr.2021.8223.
Schuster B, Gallinger J, Philipp-Dormston WG, Vasel M, Layton AM. Less confident, successful and happy: patients with post-acne hyperpigmentation are stigmatized. Br J Dermatol. 2023;188(5):682–4. https://doi.org/10.1093/bjd/ljad026.
Savory SA, Agim NG, Mao R, Peter S, Wang C, Maldonado G, et al. Reliability assessment and validation of the postacne hyperpigmentation index (PAHPI), a new instrument to measure postinflammatory hyperpigmentation from acne vulgaris. J Am Acad Dermatol. 2014;70(1):108–14. https://doi.org/10.1016/j.jaad.2013.09.017.
Auffret N, Leccia MT, Ballanger F, Claudel JP, Dahan S, Dréno B. Acne-induced post-inflammatory hyperpigmentation: from grading to treatment. Acta Derm Venereol. 2025;105:1–9. https://doi.org/10.2340/actadv.v105.42925.
Kesty CE, Kesty KR. The Kesty Hyperpigmentation Scale: a study to validate a new tool for assessing facial hyperpigmentation. J Cosmet Dermatol. 2025;24(4):e70055. https://doi.org/10.1111/jocd.70055.
Article PubMed PubMed Central Google Scholar
Dabbas D. Comparison of MELASQOL and DLQI in female patients suffering from melasma and nonmelasma facial melanosis: a cross-sectional study. Pigment Int. 2023;10(2):93–96.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210–6. https://doi.org/10.1111/j.1365-2230.1994.tb01167.x.
Article CAS PubMed Google Scholar
Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol. 1997;133(11):1433–40.
Article CAS PubMed Google Scholar
Yoshimura K, Tsukamoto K, Okazaki M, Virador VM, Lei TC, Suzuki Y, et al. Effects of all-trans retinoic acid on melanogenesis in pigmented skin equivalents and monolayer culture of melanocytes. J Dermatol Sci. 2001;27(Suppl. 1):S68-75. https://doi.org/10.1016/s0923-1811(01)00116-5.
Article CAS PubMed Google Scholar
Elias PM. Epidermal effects of retinoids: supramolecular observations and clinical implications. J Am Acad Dermatol. 1986;15(4 Pt 2):797–809. https://doi.org/10.1016/s0190-9622(86)70236-3.
Article CAS PubMed Google Scholar
Kang HY, Valerio L, Bahadoran P, Ortonne JP. The role of topical retinoids in the treatment of pigmentary disorders: an evidence-based review. Am J Clin Dermatol. 2009;10(4):251–60. https://doi.org/10.2165/00128071-200910040-00005.
Aubert J, Piwnica D, Bertino B, Blanchet-Réthoré S, Carlavan I, Déret S, et al. Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-γ agonist trifarotene. Br J Dermatol. 2018;179(2):442–56. https://doi.org/10.1111/bjd.16719.
Article CAS PubMed Google Scholar
Issa N, Alexis A, Baldwin H, Hamzavi I, Hebert A, Kwong P, et al. Recommendations to improve outcomes in acne and acne sequelae: a focus on trifarotene and other retinoids. Dermatol Ther. 2025;15(3):563–77. https://doi.org/10.1007/s13555-025-01344-y.
Bulengo-Ransby SM, Griffiths CE, Kimbrough-Green CK, Finkel LJ, Hamilton TA, Ellis CN, et al. Topical tretinoin (retinoic acid) therapy for hyperpigmented lesions caused by inflammation of the skin in Black patients. N Engl J Med. 1993;328(20):1438–43. https://doi.org/10.1056/NEJM199305203282002.
Article CAS PubMed Google Scholar
Jacyk WK, Mpofu P. Adapalene gel 0.1% for topical treatment of acne vulgaris in African patients. Cutis. 2001;68(4 Suppl.):48–54.
Grimes P, Callender
Comments (0)